SCHEMBL7263353

SCHEMBL7263353

CC(Nc1ncnc2ccc([N+](=O)[O-])cc12)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 8/20 0.65
GALR3 O60755 1/20 0.62
NR2F2 P24468 1/20 0.62
ALDH1A1 P00352 2/20 0.57
HTT P42858 2/20 0.57
GAA P10253 2/20 0.57
KRAS P01116 1/20 0.57
SOS1 Q07889 1/20 0.57
CRHBP P24387 1/20 0.54
CRHR2 Q13324 1/20 0.54
LMNA P02545 1/20 0.53
ALK Q9UM73 1/20 0.53
MAPT P10636 2/20 0.53
DYRK1A Q13627 2/20 0.52
PIK3CA P42336 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.51
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7263343 1.00 EGFR (0.65) EGFRGALR3NR2F2ALDH1A1HTT
SCHEMBL13170962 1.00 EGFR (0.65) EGFRGALR3NR2F2ALDH1A1HTT
SCHEMBL13170964 0.89 GAA (0.57) EGFRGALR3NR2F2ALDH1A1HTT
SCHEMBL13170966 0.89 GAA (0.57) EGFRGALR3NR2F2ALDH1A1HTT
SCHEMBL9921351 0.88 EGFR (0.59) EGFRGALR3NR2F2ALDH1A1HTT
SCHEMBL9921365 0.88 EGFR (0.59) EGFRGALR3NR2F2ALDH1A1HTT
SCHEMBL28509057 0.85 GALR3 (0.69) EGFRGALR3NR2F2ALDH1A1HTT
SCHEMBL28513093 0.85 HTT (0.59) EGFRGALR3NR2F2ALDH1A1HTT
SCHEMBL28505293 0.84 EGFR (0.59) EGFRGALR3NR2F2ALDH1A1HTT
SCHEMBL1366862 0.81 EGFR (0.49) EGFRGALR3NR2F2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY (CN) 2012-10-11 US disclosed
WO-2012079079-A1 PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-06-14 WO disclosed
WO-2011011522-A2 POTENT SMALL MOLECULE INHIBITORS OF AUTOPHAGY, AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2011-01-27 WO disclosed
US-6653305-B2 For therapy of tumoral diseases, diseases of the lungs and respiratory tract BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-11-25 US disclosed
US-20020077330-A1 Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2002-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020077330-A1 Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, NR3C2, CYP11B2 EGFR 417/4885GALR3 1425/4885NR2F2 1096/4885
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof ATG7, BECN1, SQSTM1 EGFR 2099/4885GALR3 1497/4885NR2F2 2764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.